Cargando…

Vaccine therapy for pancreatic cancer

Pancreatic cancer is a lethal disease and currently available therapies have significant limitations. Pancreatic cancer is thus an ideal setting for the development of novel treatment modalities such as immunotherapy. However, relevant obstacles must be overcome for immunotherapeutic regimens agains...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salman, Bulent, Zhou, Donger, Jaffee, Elizabeth M, Edil, Barish H, Zheng, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3912009/ https://www.ncbi.nlm.nih.gov/pubmed/24498551 http://dx.doi.org/10.4161/onci.26662

Ejemplares similares

Combination therapies for cancer: challenges and opportunities
por: Zhou, Zhijun, et al.
Publicado: (2023)

Genomic and single cell sequencing facilitate the dissection of heterogeneity of pancreatic tumors
por: Edil, Barish H., et al.
Publicado: (2020)

Portal Venous Stenting in Locally Advanced Pancreatic Cancer to Decrease Risk of Thrombosis Before Irreversible Electroporation: A Case Report and Review of the Literature
por: Monroe, Justin F., et al.
Publicado: (2017)

Tyrosine 23 Phosphorylation-Dependent Cell-Surface Localization of Annexin A2 Is Required for Invasion and Metastases of Pancreatic Cancer
por: Zheng, Lei, et al.
Publicado: (2011)

Neoadjuvant FOLFIRINOX Application in Borderline Resectable Pancreatic Adenocarcinoma: A Retrospective Cohort Study
por: Paniccia, Alessandro, et al.
Publicado: (2014)

Development of mutome-specific personalized vaccines for pancreatic cancer
por: Lutz, Eric, et al.
Publicado: (2013)

Messenger RNA vaccines for cancer immunotherapy: progress promotes promise
por: Huff, Amanda L., et al.
Publicado: (2022)

TGF-β blockade depletes T regulatory cells from metastatic pancreatic tumors in a vaccine dependent manner
por: Soares, Kevin C., et al.
Publicado: (2015)

Molecular, Histologic, and Radiologic Findings of High-Grade Invasive Adenocarcinoma Arising in Oncocytic Subtype of Intraductal Papillary Mucinous Neoplasm: A Case Report and Review of Literature
por: Shows, Jared, et al.
Publicado: (2017)

Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humanized pancreatic cancer murine model
por: Li, Pan, et al.
Publicado: (2022)

Stromal Annexin A2 expression is predictive of decreased survival in pancreatic cancer
por: Murphy, Adrian G., et al.
Publicado: (2017)

Nanotheranostics for Image-Guided Cancer Treatment
por: Dennahy, Isabel S., et al.
Publicado: (2022)

Actively Targeted Nanodelivery of Echinomycin Induces Autophagy-Mediated Death in Chemoresistant Pancreatic Cancer In Vivo
por: Thomas, Alexandra, et al.
Publicado: (2020)

Is it justified to assess the resectability of pancreatic cancer combined with biological and conditional factors?
por: Huang, Bingying, et al.
Publicado: (2022)

Novel therapeutic strategies and perspectives for metastatic pancreatic cancer: vaccine therapy is more than just a theory
por: Luo, Wenhao, et al.
Publicado: (2020)

Personalized pancreatic cancer therapy: from the perspective of mRNA vaccine
por: Huang, Xing, et al.
Publicado: (2022)

A feasibility study of combined epigenetic and vaccine therapy in advanced colorectal cancer with pharmacodynamic endpoint
por: Bever, Katherine M., et al.
Publicado: (2021)

Targeting myeloid-inflamed tumor with anti-CSF-1R antibody expands CD137+ effector T-cells in the murine model of pancreatic cancer
por: Saung, May Tun, et al.
Publicado: (2018)

Pancreatic Ductal Adenocarcinoma Cortical Mechanics and Clinical Implications
por: Angstadt, Shantel, et al.
Publicado: (2022)

Mesothelin-specific CD8(+) T Cell Responses Provide Evidence of In Vivo Cross-Priming by Antigen-Presenting Cells in Vaccinated Pancreatic Cancer Patients
por: Thomas, Amy Morck, et al.
Publicado: (2004)

Pancreatic Enzyme Replacement Therapy in Pancreatic Cancer
por: Pezzilli, Raffaele, et al.
Publicado: (2020)

Identification of CD112R as a novel checkpoint for human T cells
por: Zhu, Yuwen, et al.
Publicado: (2016)

Gene expression profile of human colorectal cancer identified NKTR as a biomarker for liver metastasis
por: Bai, Rui, et al.
Publicado: (2022)

NF-κB p50-deficient immature myeloid cell (p50-IMC) adoptive transfer slows the growth of murine prostate and pancreatic ductal carcinoma
por: Suresh, Rahul, et al.
Publicado: (2020)

Targeted Therapies for Pancreatic Cancer
por: Amanam, Idoroenyi, et al.
Publicado: (2018)

Nanotechnologies in Pancreatic Cancer Therapy
por: Manzur, Ayesha, et al.
Publicado: (2017)

Tumor-Associated Antigen Expressing Listeria monocytogenes Induces Effective Primary and Memory T-Cell Responses Against Hepatic Colorectal Cancer Metastases
por: Olino, Kelly, et al.
Publicado: (2011)

Olaparib in combination with irinotecan, cisplatin, and mitomycin C in patients with advanced pancreatic cancer
por: Yarchoan, Mark, et al.
Publicado: (2017)

Cancer vaccines and immunotherapeutic approaches in hepatobiliary and pancreatic cancers
por: Hochnadel, Inga, et al.
Publicado: (2017)

Proton Therapy in the Management of Pancreatic Cancer
por: Kobeissi, Jana M., et al.
Publicado: (2022)

Oncolytic viral therapy for pancreatic cancer: current research and future directions
por: Ady, Justin W, et al.
Publicado: (2014)

Establishing a framework for building multidisciplinary programs
por: Meguid, Cheryl, et al.
Publicado: (2015)

Necrotizing Pancreatitis: Current Management and Therapies
por: Boumitri, Christine, et al.
Publicado: (2017)

Biomarkers and Targeted Therapy in Pancreatic Cancer
por: Karandish, Fataneh, et al.
Publicado: (2016)

Immune checkpoint therapy for pancreatic cancer
por: Johansson, Henrik, et al.
Publicado: (2016)

Fueling the engine and releasing the break: combinational therapy of cancer vaccines and immune checkpoint inhibitors
por: Kleponis, Jennifer, et al.
Publicado: (2015)

Stereotactic Radiotherapy and Particle Therapy for Pancreatic Cancer
por: Ng, Sweet Ping, et al.
Publicado: (2018)

Neoadjuvant therapy for pancreatic cancer
por: Gugenheim, Jean, et al.
Publicado: (2021)

Nuclear Export Inhibition for Pancreatic Cancer Therapy
por: Muqbil, Irfana, et al.
Publicado: (2018)

Pancreatic Cancer: Challenges and Opportunities in Locoregional Therapies
por: Bazeed, Alaa Y., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4ga1dvf72v4igrlhhk1s9iodpl